A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Adjuvant therapy for hepatocellular carcinoma: Current situation and prospect
Drug Discoveries & Therapeutics
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, accounting for 90% of primary liver cancers, and its incidence is still increasing. While the curative treatment for HCC is surgical resection and liver transplantation, most patients are in advanced stage, and lose the chance of surgery. Other palliative treatments include radiofrequency ablation, transarterial embolization, chemotherapy, and radiotherapy. Although there are so many treatments, the prognosis ofdoi:10.5582/ddt.2013.v7.4.137 fatcat:r5qrozpoyzc5dcgvyzzta5r4rm